Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
Authors
Keywords
-
Journal
LANCET INFECTIOUS DISEASES
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-08-09
DOI
10.1016/s1473-3099(22)00291-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants
- (2022) Laura L. Hammitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study
- (2021) Jerald Sadoff et al. JOURNAL OF INFECTIOUS DISEASES
- Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial
- (2021) Tracy J Ruckwardt et al. Lancet Respiratory Medicine
- Assessing the Full Burden of Respiratory Syncytial Virus in Young Infants in Low- and Middle-Income Countries: The Importance of Community Mortality Studies
- (2021) Padmini Srikantiah et al. CLINICAL INFECTIOUS DISEASES
- Exploratory Analysis of the Economically Justifiable Price of a Hypothetical RSV Vaccine for Older Adults in the Netherlands and the United Kingdom
- (2021) F Zeevat et al. JOURNAL OF INFECTIOUS DISEASES
- Epicutaneous immunization using synthetic virus-like particles efficiently boosts protective immunity to respiratory syncytial virus
- (2021) Pierre-Louis Hervé et al. VACCINE
- An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus
- (2021) Armando Zuniga et al. npj Vaccines
- Bringing Preventive RSV Monoclonal Antibodies to Infants in Low- and Middle-Income Countries: Challenges and Opportunities
- (2021) Jintanat Ananworanich et al. Vaccines
- Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States
- (2021) William L. Herring et al. VACCINE
- Vaccine-induced immune thrombotic thrombocytopenia
- (2021) Frederikus A Klok et al. Lancet Haematology
- Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis
- (2021) Brian M. Maas et al. EBioMedicine
- LB14. Efficacy and Immunogenicity of an Ad26.RSV.preF-based Vaccine in the Prevention of RT-PCR-confirmed RSV-mediated Lower Respiratory Tract Disease in Adults Aged ≥65 Years: A Randomized, Placebo-controlled, Phase 2b Study
- (2021) Ann R Falsey et al. Open Forum Infectious Diseases
- Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children
- (2020) Elizabeth J McFarland et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trial
- (2020) Nathaly Samy et al. VACCINE
- A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates
- (2020) Steffen Mueller et al. VACCINE
- Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries
- (2020) Xiao Li et al. BMC Medicine
- Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine With an Adenovirus 26 Vector Encoding Prefusion F (Ad26.RSV.preF) in Adults Aged ≥60 Years
- (2020) Kristi Williams et al. JOURNAL OF INFECTIOUS DISEASES
- Broad Antibody and Cellular Immune Response from a Phase 2 Clinical Trial with a Novel Multivalent Poxvirus Based RSV Vaccine
- (2020) Elke Jordan et al. JOURNAL OF INFECTIOUS DISEASES
- SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
- (2020) Kizzmekia S. Corbett et al. NATURE
- Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants
- (2020) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants
- (2020) M. Pamela Griffin et al. NEW ENGLAND JOURNAL OF MEDICINE
- First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity: a randomized controlled trial
- (2020) Pauline Verdijk et al. VACCINE
- Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein
- (2020) Heather L. Torrey et al. Human Vaccines & Immunotherapeutics
- Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults
- (2020) Felicia Scaggs Huang et al. Human Vaccines & Immunotherapeutics
- Adenovector 26 encoded prefusion conformation stabilized RSV-F protein induces long-lasting Th1-biased immunity in neonatal mice
- (2020) Leslie van der Fits et al. npj Vaccines
- Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children
- (2020) Ruth A Karron et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants
- (2020) Eric A F Simões et al. CLINICAL INFECTIOUS DISEASES
- Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults
- (2020) Jerald Sadoff et al. JOURNAL OF INFECTIOUS DISEASES
- Update on rotavirus vaccine underperformance in low- to middle-income countries and next-generation vaccines
- (2020) Benjamin Lee Human Vaccines & Immunotherapeutics
- Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus
- (2019) Jessica Marcandalli et al. CELL
- First-in-human randomized study to assess the safety and immunogenicity of an investigational respiratory syncytial virus (RSV) vaccine based on ChAd155 viral vector expressing RSV viral proteins F, N and M2-1 in healthy adults
- (2019) Paola Cicconi et al. CLINICAL INFECTIOUS DISEASES
- A proof of concept for structure-based vaccine design targeting RSV in humans
- (2019) Michelle C. Crank et al. SCIENCE
- An ethics framework and practical guidance for post-trial access to an RSV maternal vaccine
- (2019) Natalie I Mazur et al. Lancet Respiratory Medicine
- Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/ΔNS2/Δ1313/I1314L in RSV-Seronegative Children
- (2019) Ruth A Karron et al. JOURNAL OF INFECTIOUS DISEASES
- A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein
- (2019) Aimin Tang et al. Nature Communications
- Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis
- (2019) Shanshan Zhang et al. JOURNAL OF INFECTIOUS DISEASES
- A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study
- (2018) Joanne M Langley et al. JOURNAL OF INFECTIOUS DISEASES
- Prevalence and Significance of Substitutions in the Fusion Protein of Respiratory Syncytial Virus Resulting in Neutralization Escape From Antibody MEDI8897
- (2018) Qing Zhu et al. JOURNAL OF INFECTIOUS DISEASES
- The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates
- (2018) Natalie I Mazur et al. LANCET INFECTIOUS DISEASES
- Down Syndrome and the Risk of Severe RSV Infection: A Meta-analysis
- (2018) Andrea A. Beckhaus et al. PEDIATRICS
- Severe Morbidity and Mortality Associated With Respiratory Syncytial Virus Versus Influenza Infection in Hospitalized Older Adults
- (2018) Bradley Ackerson et al. CLINICAL INFECTIOUS DISEASES
- A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease
- (2017) Marian Alexander Wiegand et al. JOURNAL OF VIROLOGY
- Maternal Immunization
- (2017) Saad B. Omer NEW ENGLAND JOURNAL OF MEDICINE
- Genetic stability of genome-scale deoptimized RNA virus vaccine candidates under selective pressure
- (2017) Cyril Le Nouën et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series
- (2017) Nienke M Scheltema et al. Lancet Global Health
- Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization
- (2016) Vincent Ahonkhai et al. PLoS One
- A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation
- (2016) Christopher C. Stobart et al. Nature Communications
- Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus
- (2016) April M. Killikelly et al. Scientific Reports
- Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization
- (2016) Marta C. Nunes et al. JAMA Pediatrics
- Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus
- (2015) Maximillian S. Habibi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera
- (2015) Joan O. Ngwuta et al. Science Translational Medicine
- A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism
- (2015) Anders Krarup et al. Nature Communications
- RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection
- (2015) Agnieszka Jozwik et al. Nature Communications
- RSV Vaccine-Enhanced Disease Is Orchestrated by the Combined Actions of Distinct CD4 T Cell Subsets
- (2015) Cory J. Knudson et al. PLoS Pathogens
- Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics
- (2015) Natalie I Mazur et al. Lancet Respiratory Medicine
- Maternal Immunization
- (2014) H. Y. Chu et al. CLINICAL INFECTIOUS DISEASES
- Respiratory Syncytial Virus Transplacental Antibody Transfer and Kinetics in Mother-Infant Pairs in Bangladesh
- (2014) Helen Y. Chu et al. JOURNAL OF INFECTIOUS DISEASES
- Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
- (2013) J. S. McLellan et al. SCIENCE
- Strategic priorities for respiratory syncytial virus (RSV) vaccine development
- (2013) L.J. Anderson et al. VACCINE
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Rafael Lozano et al. LANCET
- Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes
- (2011) J. S. McLellan et al. JOURNAL OF VIROLOGY
- Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis
- (2011) Harish Nair et al. LANCET
- Severe respiratory syncytial virus (RSV) infection in infants with neuromuscular diseases and immune deficiency syndromes
- (2009) Bernhard Resch et al. Paediatric Respiratory Reviews
- Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze
- (2008) Lone Graff Stensballe et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search